1 R. R. Armola, "Upgrading the American Association of Critical-Care Nurses' Evidence-Leveling Hierarchy" AACN Publishing 18 (18): 405-409, 2009
2 Juan Morote, "The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness" Wiley 104 (104): 486-489, 2009
3 Yu Seob Shin, "The relationship between serum total testosterone and free testosterone levels with serum hemoglobin and hematocrit levels: a study in 1221 men" Informa UK Limited 19 (19): 209-214, 2016
4 Robin Whittemore, "The integrative review: updated methodology" Wiley 52 (52): 546-553, 2005
5 Po-Fan Hsieh, "The impact of gender and size on the pathology of small renal mass" Wiley 28 (28): 369-372, 2012
6 Christopher S. Cooper, "The effect of exogenous testosterone on total and free prostate specific antigen levels in healthy young men" Ovid Technologies (Wolters Kluwer Health) 156 : 438-441, 1996
7 Thomas J. Walsh, "Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels" Public Library of Science (PLoS) 13 (13): e0199194-, 2018
8 Hunter Mermall, "Temporal (circadian) and functional relationship between prostate-specific antigen and testosterone in healthy men" Elsevier BV 46 (46): 45-53, 1995
9 구진모, "Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml" 대한비뇨의학회 51 (51): 831-835, 2010
10 Abraham Morgentaler, "Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth" Elsevier BV 55 (55): 310-321, 2009
1 R. R. Armola, "Upgrading the American Association of Critical-Care Nurses' Evidence-Leveling Hierarchy" AACN Publishing 18 (18): 405-409, 2009
2 Juan Morote, "The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness" Wiley 104 (104): 486-489, 2009
3 Yu Seob Shin, "The relationship between serum total testosterone and free testosterone levels with serum hemoglobin and hematocrit levels: a study in 1221 men" Informa UK Limited 19 (19): 209-214, 2016
4 Robin Whittemore, "The integrative review: updated methodology" Wiley 52 (52): 546-553, 2005
5 Po-Fan Hsieh, "The impact of gender and size on the pathology of small renal mass" Wiley 28 (28): 369-372, 2012
6 Christopher S. Cooper, "The effect of exogenous testosterone on total and free prostate specific antigen levels in healthy young men" Ovid Technologies (Wolters Kluwer Health) 156 : 438-441, 1996
7 Thomas J. Walsh, "Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels" Public Library of Science (PLoS) 13 (13): e0199194-, 2018
8 Hunter Mermall, "Temporal (circadian) and functional relationship between prostate-specific antigen and testosterone in healthy men" Elsevier BV 46 (46): 45-53, 1995
9 구진모, "Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml" 대한비뇨의학회 51 (51): 831-835, 2010
10 Abraham Morgentaler, "Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth" Elsevier BV 55 (55): 310-321, 2009
11 Giulia Rastrelli, "Serum PSA as a Predictor of Testosterone Deficiency" Elsevier BV 10 (10): 2518-2528, 2013
12 David W. Keetch, "Serial Prostatic Biopsies in Men with Persistently Elevated Serum Prostate Specific Antigen Values" Ovid Technologies (Wolters Kluwer Health) 151 (151): 1571-1574, 1994
13 Mahmoud Mustafa, "Relationship between serum PSA and testosterone levels in two different geographic regions of Turkey" AVES Publishing Co 37 (37): 9-13, 2011
14 Vincenzo Favilla, "Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia" Wiley 106 (106): 1700-1703, 2010
15 Mifsud A, "Proste-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men" 7 (7): 1007-1013, 2001
16 Gerstenbluth RE, "Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement" 23 (23): 922-926, 2002
17 M. Akdogan, "Prostate-Specific Antigen Levels among Cirrhotic Patients" SAGE Publications 17 (17): 161-164, 2002
18 Abraham Morgentaler, "Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less" Elsevier BV 68 (68): 1263-1267, 2006
19 Mustafa M, "PSA and testosterone serum levels in the Middle east: Is there a difference?" 2 (2): 1028-1031, 2015
20 J. Zhang, "Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China" FapUNIFESP (SciELO) 49 (49): e5272-, 2016
21 Albuquerque GAML, "Low serum testosterone is a predictor of high-grade disease in patient with prostate cancer" 63 (63): 704-710, 2017
22 Mahmoud Mustafa, "Is There an Association Between Serum Prostate-Specific Antigen Values and Serum Testosterone Levels in Healthy Men?" The Korean Urological Association 55 (55): 465-468, 2014
23 Ahmad Haider, "Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries" Ovid Technologies (Wolters Kluwer Health) 193 (193): 80-86, 2015
24 Georg Schatzl, "High-grade prostate cancer is associated with low serum testosterone levels" Wiley 47 (47): 52-58, 2001
25 Simone Albisinni, "Greater Percent-free Testosterone Is Associated With High-grade Prostate Cancer in Men Undergoing Prostate Biopsy" Elsevier BV 80 (80): 162-168, 2012
26 Shea JL, "Free testosterone : clinical utility and important analytical aspects of measurement" 63 : 59-84, 2014
27 Promise N. Wichendu, "Endogenous testosterone to prostate-specific antigen relationship in men without prostatic diseases: a 10-year retrospective study" Medip Academy 5 (5): 1186-1191, 2018
28 Peter Boyle, "Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis" Wiley 118 (118): 731-741, 2016
29 Sahir Kilic, "Determination of the site of metabolism of total, free, and complexed prostate-specific antigen" Elsevier BV 52 (52): 470-473, 1998
30 Mustafa Sofikerim, "Correlation of Serum Androgens and Pituitary Hormone Levels with Serum PSA Less Than 2.5 NG/ML" Hindawi Limited 7 : 1128-1133, 2007
31 Drew McLaren, "Clinical practice experience with testosterone treatment in men with testosterone deficiency syndrome" Wiley 102 (102): 1142-1146, 2008
32 Sarah B. Peskoe, "Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer" Wiley 75 (75): 1167-1176, 2015
33 STEPHEN R. PLYMATE, "Circadian Variation in Testosterone, Sex Hormone-Binding Globulin, and Calculated Non-Sex Hormone-Binding Globulin Bound Testosterone in Healthy Young and Elderly Men" Wiley 10 (10): 366-371, 1989
34 Saad Elzanaty, "Association between Serum Testosterone and PSA Levels in Middle-Aged Healthy Men from the General Population" Ovid Technologies (Wolters Kluwer Health) 10 (10): 40-44, 2017
35 K. Arunprasad, "Association between Low Serum Testosterone and Prostate Cancer Behaviour" Marwah Infotech 5 (5): H1-H4, 2018
36 A. Shukla, "Association Between Serum Testosterone and Serum PSA Among Men With and Without Partial Androgen Deficiency" Springer Science and Business Media LLC 35 (35): 127-131, 2020
37 Fabio C. Vicentini, "Are Total Prostate-specific Antigen Serum Levels in Cirrhotic Men Different From Those in Normal Men?" Elsevier BV 73 (73): 1032-1035, 2009
38 National Cancer Information Center, "Annual report on the prevalences of cancer" National Cancer Center
39 Alan W. Partin, "Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and age" Elsevier BV 48 (48): 55-61, 1996
40 Young Deuk Choi, "Age-Specific Prostate-Specific Antigen Reference Ranges in Korean Men" Elsevier BV 70 (70): 1113-1116, 2007
41 Mohit Khera, "A New Era of Testosterone and Prostate Cancer: From Physiology to Clinical Implications" Elsevier BV 65 (65): 115-123, 2014